Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Enovis Corp (NYSE: ENOV) was $27.02 for the day, down -3.36% from the previous closing price of $27.96. In other words, the price has decreased by -$3.36 from its previous closing price. On the day, 1.53 million shares were traded. ENOV stock price reached its highest trading level at $28.515 during the session, while it also had its lowest trading level at $26.73.
Ratios:
Our analysis of ENOV’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 45.96 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 67.86. For the most recent quarter (mrq), Quick Ratio is recorded 1.16 and its Current Ratio is at 2.22. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.69.
Upgrades & Downgrades
In the most recent recommendation for this company, JMP Securities on October 03, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $62.
On June 13, 2024, JP Morgan started tracking the stock assigning a Neutral rating and target price of $53.
On February 13, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $72.Stephens initiated its Overweight rating on February 13, 2024, with a $72 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 25 ’25 when KLECKNER JOHN bought 2,468 shares for $30.32 per share. The transaction valued at 74,830 led to the insider holds 12,302 shares of the business.
McDonald Damien bought 6,457 shares of ENOV for $199,973 on Sep 11 ’25. The Chief Executive Officer now owns 102,753 shares after completing the transaction at $30.97 per share. On Aug 22 ’25, another insider, Tandy Bradley J, who serves as the SVP and Chief Legal Officer of the company, bought 3,200 shares for $31.41 each. As a result, the insider paid 100,512 and bolstered with 43,515 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ENOV now has a Market Capitalization of 1545257088 and an Enterprise Value of 2955897088. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.69 while its Price-to-Book (P/B) ratio in mrq is 0.76. Its current Enterprise Value per Revenue stands at 1.324 whereas that against EBITDA is 8.01.
Stock Price History:
The Beta on a monthly basis for ENOV is 1.28, which has changed by -0.43031836 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, ENOV has reached a high of $49.38, while it has fallen to a 52-week low of $25.47. The 50-Day Moving Average of the stock is -11.27%, while the 200-Day Moving Average is calculated to be -16.43%.
Shares Statistics:
ENOV traded an average of 794.48K shares per day over the past three months and 817850 shares per day over the past ten days. A total of 57.19M shares are outstanding, with a floating share count of 55.88M. Insiders hold about 2.28% of the company’s shares, while institutions hold 114.56% stake in the company. Shares short for ENOV as of 1763078400 were 7754149 with a Short Ratio of 9.76, compared to 1760486400 on 7170793. Therefore, it implies a Short% of Shares Outstanding of 7754149 and a Short% of Float of 20.380000000000003.
Earnings Estimates
Current recommendations for the stock of the company come from 10.0 analysts. The consensus estimate for the next quarter is $0.77, with high estimates of $0.85 and low estimates of $0.63.
Analysts are recommending an EPS of between $3.25 and $3.15 for the fiscal current year, implying an average EPS of $3.19. EPS for the following year is $3.44, with 10.0 analysts recommending between $3.6 and $3.25.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 10 analysts. It ranges from a high estimate of $593.73M to a low estimate of $580.4M. As of. The current estimate, Enovis Corp’s year-ago sales were $560.98MFor the next quarter, 10 analysts are estimating revenue of $581.67M. There is a high estimate of $592.77M for the next quarter, whereas the lowest estimate is $566.2M.
A total of 10 analysts have provided revenue estimates for ENOV’s current fiscal year. The highest revenue estimate was $2.27B, while the lowest revenue estimate was $2.25B, resulting in an average revenue estimate of $2.26B. In the same quarter a year ago, actual revenue was $2.11BBased on 10 analysts’ estimates, the company’s revenue will be $2.36B in the next fiscal year. The high estimate is $2.41B and the low estimate is $2.32B.
